Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Other Non-Current Assets (2020 - 2022)

Atea Pharmaceuticals has reported Other Non-Current Assets over the past 3 years, most recently at $305000.0 for Q3 2022.

  • Quarterly results put Other Non-Current Assets at $305000.0 for Q3 2022, changed 0.0% from a year ago — trailing twelve months through Sep 2022 was $305000.0 (changed 0.0% YoY), and the annual figure for FY2021 was $305000.0, up 185.05%.
  • Other Non-Current Assets for Q3 2022 was $305000.0 at Atea Pharmaceuticals, roughly flat from $305000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for AVIR hit a ceiling of $1.6 million in Q3 2020 and a floor of $107000.0 in Q4 2020.
  • Median Other Non-Current Assets over the past 3 years was $305000.0 (2021), compared with a mean of $387777.8.
  • Peak annual rise in Other Non-Current Assets hit 185.05% in 2021, while the deepest fall reached 81.45% in 2021.
  • Atea Pharmaceuticals' Other Non-Current Assets stood at $107000.0 in 2020, then surged by 185.05% to $305000.0 in 2021, then changed by 0.0% to $305000.0 in 2022.
  • The last three reported values for Other Non-Current Assets were $305000.0 (Q3 2022), $305000.0 (Q2 2022), and $305000.0 (Q1 2022) per Business Quant data.